The minimally invasive and non-invasive surgeries are gaining popularity these days due to the minimized risk related with such procedures. The incidence of uterine fibroids in women is on the rise worldwide, which can cause amenorrhea, dysmenorrhea, abnormal uterine bleeding, and pelvic or abdominal pressure. The increasing awareness programs by numerous organizations are surging the demand for fibroid treatment devices globally.
According to Data Bridge Market Research the Global Morcellators Market which was USD 115 million in 2021, would rocket up to USD 205.10 million by 2029, and is expected to undergo a CAGR of 7.50 % during the forecast period 2022 to 2029.
“Increasing Rates of Uterine Fibroids Facilitate the Market Growth”
The prevalence of uterine fibroids in women is on the rise worldwide, and these can cause abnormal amenorrhea, dysmenorrhea, pelvic or abdominal pressure, uterine bleeding. It is expected that not all women suffering from uterine fibroids have symptoms and about 50 to 75% of cases remain asymptomatic and often remain undiagnosed. Therefore, it is projected that about 77% of women of childbearing age could have uterine fibroids. According to the NCBI study report, in the U.S., about 30,000 myomectomies are performed yearly for leiomyomata. The incidence of uterine fibroids rises as women age and may occur in over 30% of women aged between 40 to 60 years. All these factors are lead to the growth of the market.
What restraints the growth of Global Morcellators Market?
“Product recall from the regulatory authorities”
The product recall from the regulatory authorities is anticipated to impede the growth of the global morcellators market during the forecast period. For instance, the US FDA issued a recall notice for the PneumoLiner device on October 26, 2021 which is intended for use as a tissue containment system during minimally invasive gynecologic laparoscopic surgery, manufactured by Olympus Corporation of the Americas has received recall notification from the U.S. Food and Drug Administration because of the manufacturing error.
Segmentation: Global Morcellators Market
The morcellators market is segmented on the basis of type, application, usage type and end user.
- Based on type, the morcellators market is segmented into electric morcellator, manual morcellator, and others.
- Based on application, the morcellators market is segmented into hospitals, ambulatory surgical centers, specialty clinics and others.
- Based on usage type, the morcellators market is bifurcated into reusable, reposable, and disposable.
- Based on end user, the morcellators market is bifurcated into uterine fibroids, hysteroscopy, laparoscopy, and others.
Regional Insights: North America is expected to dominate the Global Morcellators Market
North America dominates the market because of the good healthcare foundation and laparoscopic technological advancements. Also, the increasing incidence of uterine cancer is boosting the market growth. For instance, as per the American Society of Clinical Oncology (ASCO), 66,570 women are expected to be diagnosed with uterine cancer, commonly known as endometrial cancer in 2021 in the U.S.
Asia-Pacific is expected to grow in the forecast period of 2022-2029 because of the increasing health awareness among the people and rising demand of advanced medical technology. The increasing patient pool suffering from numerous disorders such as endometritis, abnormal bleeding, uterine fibroids, and subsequent increase in the number of myomectomy and hysterectomy surgeries is estimated to boost the demand for morcellators in the Asia Pacific region.
To know more about the study visit, https://www.databridgemarketresearch.com/fr/reports/global-morcellators-market
Recent Developments in Global Morcellators Market
- In 2020, Minerva Surgical acquired the Intrauterine Health products segment from Boston Scientific Corporation. The segment include products such as Resect Tissue Resection Device, Symphion Tissue Removal System, and the Genesys HTA System utilized for the treatment of irregular uterine bleeding and other associated disorders.
- In 2021, Olympus America specified that it supported the U.S. Food and Drug Administration published guidance recommendations signifying that laparoscopic power morcellators in gynecological procedures must be performed using an approved containment device.
The Prominent Key Players Operating in the Global Morcellators Market Include:
- Johnson & Johnson Private Limited (U.S.)
- Blue Endo (U.S.)
- Karl Storz (Germany)
- Richard Wolf GmbH (Germany)
- FemRx Templeton (U.S.)
- Lumenis Be LTD. (Israel)
- Hologic Inc. (U.S.)
- Smith+Nephew (U.S.)
- Olympus Corporation (Japan)
- Nouvag (Germany)
- LiNA Medical ApS (Denmark)
- Medtronic (Ireland)
- Stryker (U.S.)
- C. R. Bard, Inc. (U.S.)
- Cook Urological, Inc. (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of global morcellators market companies contact, https://www.databridgemarketresearch.com/fr/contact
Research Methodology: Global Morcellators Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
